• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Pharmacyclics Inc. (PCYC)

    -NasdaqGS
    215.93 Down 1.89(0.87%) Feb 27, 4:00PM EST
    Add to Portfolio
    Prev Close:217.82
    Open:214.12
    Bid:4.50 x 200
    Ask:N/A
    1y Target Est:194.58
    Beta:0.74
    Next Earnings Date:N/A
    Day's Range:214.01 - 220.79
    52wk Range:82.51 - 231.09
    Volume:2,025,015
    Avg Vol (3m):1,108,880
    Market Cap:16.41B
    P/E (ttm):196.30
    EPS (ttm):1.10
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PCYCDown 0.87%16.41B
    CTICDown 1.68%339.62M
    MRKDown 0.71%166.89B

    Key Statistics

    Forward P/E (1 yr):53.85
    P/S (ttm):22.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.78
    Quarterly EPS Est (Mar-15) :0.13
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):1,730.19

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Pharmacyclics, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for the treatment of cancer and immune-mediated diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback